[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kimber, 2001 - Google Patents

Mechanical strain-induced regulation of vascular endothelial growth factor production by human vascular smooth muscle cells

Kimber, 2001

View PDF
Document ID
10661512586445673199
Author
Kimber P
Publication year
Publication venue
PQDT-UK & Ireland

External Links

Snippet

The present thesis investigates the effect of cyclical mechanical strain on the expression of vascular endothelial growth factor (VEGF); a potent cytokine produced by human vascular smooth muscle cells (VSMC). The initial investigations observed the expression of VEGF …
Continue reading at figshare.le.ac.uk (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells

Similar Documents

Publication Publication Date Title
Pérez-Gutiérrez et al. Biology and therapeutic targeting of vascular endothelial growth factor A
US7064185B2 (en) Antibody for human Cyr61
Ribatti et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
Klagsbrun et al. The role of neuropilin in vascular and tumor biology
Roskoski Jr Vascular endothelial growth factor (VEGF) signaling in tumor progression
KR100628697B1 (en) Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
JP4669968B2 (en) Methods for regulating hematopoiesis and angiogenesis
US7125714B2 (en) Progenitor cell materials and methods
US20080057028A1 (en) Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells
AU2001234721B2 (en) Human Cyr61
US20060025338A1 (en) Compositions and methods for treatment of lymphatic and venous vessel arterialization
Kimber Mechanical strain-induced regulation of vascular endothelial growth factor production by human vascular smooth muscle cells
Bassing et al. Receptors for the TGF-β ligand family
US6960444B2 (en) Transcriptional mediators of blood vessel development and endothelial differentiation
KR101723292B1 (en) Composition comprising KAI1 polypeptide or nucleic acids encoding the same for inhibiting angiogenesis, and uses thereof
Maru et al. An oncogenic form of the Flt-1 kinase has a tubulogenic potential in a sinusoidal endothelial cell line
US20040002124A1 (en) Cyr61 compositions and methods
Browning The isolation, characterisation and investigation into the In vitro behaviour of human ocular vascular endothelial cells
Lim Roles Of Vegfc And Vegfr3 In Lymphangiogenesis And Angiogenesis
JP4324709B2 (en) Receptor ligand VEGF-C
JP4324709B6 (en) Receptor ligand VEGF-C
AU2007242926A1 (en) Extracellular matrix signalling molecules
McCarthy Studies on the endothelial cell specific receptor tyrosine kinase, tie-1
Grass Regulation of angiogenesis and vascular remodeling by angiogenic factors
Howson The roles of VEGF and angiopoietin-1 in modulating pericyte and endothelial cell behaviour in vitro